[1
]Investigational Drug Disposition, Eli Lilly and Company, Lilly Corporate Center, DC0714,
Indianapolis, IN 46285, USA; Tel: 317-277-4324
[2
]Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co.,
Inc., Kenilworth, New Jersey 07033, USA; 732-594-0977
[3
]Pharmaceutical Sciences, Pharmaceutical Research and Early Development, Roche Innovation
Centre Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
[4
]Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of
Pharmacy, The University of North Carolina at Chapel Hill, CB #7569 Kerr Hall, Chapel
Hill, NC 27599-7569, USA; Tel: (919) 962-7030
[5
]Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug
Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave,
Silver Spring, MD 20993, USA; 301-796-1541
[6
]Temple University School of Pharmacy, Department of Pharmaceutical Sciences, 3307
N Broad Street, Philadelphia PA 19140, USA; 215-707-9110
[7
]Department of Pharmacy, Uppsala University, Box 580, SE-75123 Uppsala, Sweden +46-(0)18-471
46 30
[8
]Safety and ADME Translational Sciences, Drug Safety and Metabolism, IMED Biotech Unit,
AstraZeneca R&D, Cambridge CB4 0WG, UK
[9
]Department of Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium;
Tel: +32-14606812
[10
]Sugiyama Laboratory, RIKEN Innovation Center, RIKEN Research Cluster for Innovation,
Yokohama 230-0045, Japan; Tel: (045) 506-1814
[11
]Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co.,
Inc., Kenilworth, New Jersey 07033, USA; 908-464-2375
[12
]Department of Pharmaceutics, University of Washington, Seattle, WA, USA; 206-685-2869
[13
]Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University
of Manchester, Manchester M13 9PT, UK; + 44-161-275-6886